Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 12, 2001 - Issue 1
Submit an article Journal homepage
102
Views
32
CrossRef citations to date
0
Altmetric
Research Article

The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum

JH Hagman University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
AM Carrozzo University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
E Campione University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
P Romanelli University of Miami School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, Florida, USA
&
S Chimenti University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
Pages 19-22 | Published online: 12 Jul 2009

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

J Mark Jackson & Jeffrey P Callen. (2006) Pyoderma gangrenosum: an expert commentary. Expert Review of Dermatology 1:3, pages 391-400.
Read now
Cindy Berthelot & Jennifer Clay Cather. (2005) Violaceous-Rimmed Ulcers. Baylor University Medical Center Proceedings 18:2, pages 175-178.
Read now

Articles from other publishers (30)

Emanual Maverakis, Angelo V. Marzano, Stephanie T. Le, Jeffrey P. Callen, Marie-Charlotte Brüggen, Emmanuella Guenova, Joachim Dissemond, Kanade Shinkai & Sinéad M. Langan. (2020) Pyoderma gangrenosum. Nature Reviews Disease Primers 6:1.
Crossref
Katharina Herberger, Joachim Dissemond, Sarah Brüggestrat, Christina Sorbe & Matthias Augustin. (2019) Biologika und Immunglobuline für die Therapie des Pyoderma gangraenosum – Analyse von 52 Patienten. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17:1, pages 32-42.
Crossref
Katharina Herberger, Joachim Dissemond, Sarah Brüggestrat, Christina Sorbe & Matthias Augustin. (2018) Biologics and immunoglobulins in the treatment of pyoderma gangrenosum – analysis of 52 patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17:1, pages 32-41.
Crossref
H. Song, N. LahoodA. Mostaghimi. (2018) Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series. British Journal of Dermatology 178:2, pages 363-368.
Crossref
Cole Sterling, Genevieve M. Crane, Jihad Al-hariri & Satish Shanbhag. (2017) Double Jeopardy: Autoimmune Myelofibrosis with Pyoderma Gangrenosum. The American Journal of Medicine 130:1, pages e1-e4.
Crossref
K. Herberger. (2016) Pyoderma gangraenosumPyoderma gangrenosum. Der Hautarzt 67:9, pages 753-763.
Crossref
John Cafardi & Naveed Sami. (2014) Intravenous Immunoglobulin as Salvage Therapy in Refractory Pyoderma Gangrenosum: Report of a Case and Review of the Literature. Case Reports in Dermatology 6:3, pages 239-244.
Crossref
Tobias Goerge & Thomas A. Luger. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 389 396.e3 .
Iris Ahronowitz, Joanna Harp & Kanade Shinkai. (2012) Etiology and Management of Pyoderma Gangrenosum. American Journal of Clinical Dermatology 13:3, pages 191-211.
Crossref
Vincent Falanga, Christina Lindholm, Polly A. Carson, Jaymie Panuncialman, Lisa Mamakos, Tiziana N. Lotti & Jane K. Falanga. 2012. Text Atlas of Wound Management. Text Atlas of Wound Management 207 218 .
Kristin M. Nord, Amy S. Pappert & Marc E. Grossman. (2011) Pyoderma Gangrenosum‐like Lesions in Leukocyte Adhesion Deficiency I Treated with Intravenous Immunoglobulin. Pediatric Dermatology 28:2, pages 156-161.
Crossref
Jaymie Panuncialman & Vincent Falanga. (2010) Unusual Causes of Cutaneous Ulceration. Surgical Clinics of North America 90:6, pages 1161-1180.
Crossref
Sally E de Zwaan, Harry J Iland & Diona L Damian. (2009) Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. Australasian Journal of Dermatology 50:1, pages 56-59.
Crossref
CE Foss, AR Clark, R Inabinet, F Camacho & JL Jorizzo. (2008) An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. Journal of the European Academy of Dermatology and Venereology 22:8, pages 943-949.
Crossref
A. Kreuter, S. Reich-Schupke, M. St?cker, P. Altmeyer & T. Gambichler. (2008) Intravenous immunoglobulin for pyoderma gangrenosum. British Journal of Dermatology 158:4, pages 856-857.
Crossref
Kenichiro Tamaki, Takashi Nakazawa, Akira Mamehara, Goh Tsuji, Katsuyasu Saigo, Seiji Kawano, Akio Morinobu & Shunichi Kumagai. (2008) Successful Treatment of Pyoderma Gangrenosum Associated with Myelodysplastic Syndrome Using High-Dose Intravenous Immunoglobulin. Internal Medicine 47:23, pages 2077-2081.
Crossref
D.L. Cummins, G.J. Anhalt, T. Monahan & J.H. Meyerle. (2007) Treatment of pyoderma gangrenosum with intravenous immunoglobulin. British Journal of Dermatology 157:6, pages 1235-1239.
Crossref
Jeffrey P. Callen & J. Mark Jackson. (2007) Pyoderma Gangrenosum: An Update. Rheumatic Disease Clinics of North America 33:4, pages 787-802.
Crossref
Anthony P Fernandez & Francisco A Kerdel. (2007) The use of i.v. IG therapy in dermatology. Dermatologic Therapy 20:4, pages 288-305.
Crossref
VIR-SINGH NEGI, SRIRAMULU ELLURU, SOPHIE SIBÉRIL, STÉPHANIE GRAFF-DUBOIS, LUC MOUTHON, MICHEL D. KAZATCHKINE, SÉBASTIEN LACROIX-DESMAZES, JAGADEESH BAYRY & SRINI V. KAVERI. (2007) Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action. Journal of Clinical Immunology 27:3, pages 233-245.
Crossref
David I. Smith, Pooja M. Swamy & Michael P. Heffernan. (2007) Off-label uses of biologics in dermatology: Interferon and intravenous immunoglobulin (Part 1 of 2). Journal of the American Academy of Dermatology 56:1, pages e1-e54.
Crossref
Mary Jo. J. Kerns, Julia E. Graves, David I. Smith & Michael P. Heffernan. (2006) Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update. Seminars in Cutaneous Medicine and Surgery 25:4, pages 226-240.
Crossref
Jaymie Panuncialman & Vincent Falanga. (2006) Basic approach to inflammatory ulcers. Dermatologic Therapy 19:6, pages 365-376.
Crossref
P. Régine Mydlarski, Vincent Ho & Neil H. Shear. (2016) Canadian Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in Dermatology. Journal of Cutaneous Medicine and Surgery 10:5, pages 205-221.
Crossref
Stephen Jolles & Jenny Hughes. (2006) Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. International Immunopharmacology 6:4, pages 579-591.
Crossref
Nicolas Meyer, Val??rie Ferraro, Marie-Henriette Mignard, Henri Adamski & Jacqueline Chevrant-Breton. (2006) Pyoderma Gangrenosum Treated??with??High-Dose Intravenous Immunoglobulins. Clinical Drug Investigation 26:9, pages 541-546.
Crossref
S Jolles, W A C Sewell & S A Misbah. (2005) Clinical uses of intravenous immunoglobulin. Clinical and Experimental Immunology 142:1, pages 1-11.
Crossref
Syed Asghar. 2004. Skin Immune System. Skin Immune System 723 744 .
Angela Ehling, Sigrid Karrer, Frank Klebl, Andreas Schäffler & Ulf Müller‐Ladner. (2004) Therapeutic management of pyoderma gangrenosum. Arthritis & Rheumatism 50:10, pages 3076-3084.
Crossref
S. M. Breathnach, C. E. M. Griffiths, R. J. G. Chalmers & R. J. Hay. 2004. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 3715 3764 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.